← FDA DRUG APPROVALS

FDA ANDA · ANDA040015

NEOSAR

Sponsor: TEVA PARENTERAL

APPLICATION
ANDA040015
TYPE
ANDA
ORIGINAL APPROVAL
1993-04-29
LATEST ACTION
2002-03-25
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

NEOSARDiscontinued
CYCLOPHOSPHAMIDE 2GM/VIAL · INJECTABLE · INJECTION
NEOSARDiscontinued
CYCLOPHOSPHAMIDE 500MG/VIAL · INJECTABLE · INJECTION
NEOSARDiscontinued
CYCLOPHOSPHAMIDE 100MG/VIAL · INJECTABLE · INJECTION
NEOSARDiscontinued
CYCLOPHOSPHAMIDE 1GM/VIAL · INJECTABLE · INJECTION
NEOSARDiscontinued
CYCLOPHOSPHAMIDE 200MG/VIAL · INJECTABLE · INJECTION

Approval history

2002-03-25Labeling · Supplement 2AP
1993-08-19Labeling · Supplement 1AP
1993-04-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →